Conquering cancer requires information and dialogue. Our print and online resources make it easy to stay up-to-date on CRI’s role in helping to advance cancer immunotherapy research and treatment. We also offer information especially for patients and their families, as well as for current and prospective donors.
For the latest news, sign up for our e-alerts or subscribe to our blog. You can also read our print publications, view our videos, and access our guides and other resources for patients for more information. If you would like more information, call us at (800) 99-CANCER or send us a message via our Contact Us page.
Our blog features the latest updates from the front lines of cancer immunotherapy, including new scientific and clinical breakthroughs, news stories, and program announcements. Read the latest stories here or go to our blog to see all of our posts and subscribe to receive alerts when new stories are posted.
September 16, 2014
| Alexandra Mulvey
Bristol Myers-Squibb and Jacques C. Nordeman will receive the 2014 award for their fundraising or awareness efforts to cancer research.
awards & honors, events
September 4, 2014
| Jill O'Donnell-Tormey, Ph.D.
Merck's new immunotherapy, Keytruda (pembrolizumab), was approved today by the FDA, making it the first PD-1 inhibitor cleared in the US.
cancer immunotherapy, checkpoint-inhibitor, PD-1, progress
September 3, 2014
| Matthew Tontonoz
Four scientists to be honored with the 2014 Coley Award for their contributions to the discovery of the PD-1 pathway.
awards & honors, PD-1, research awards